Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
about
Cytomegalovirus antivirals and development of improved animal modelsAntigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human AntibodiesStructural modelling and mutagenesis of human cytomegalovirus alkaline nuclease UL98Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL.A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell typesNeutralizing activity of saliva against cytomegalovirus.Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine.Soluble Human Cytomegalovirus gH/gL/pUL128-131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing EpitopesHuman Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism.A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.Alphaherpesvirinae and Gammaherpesvirinae glycoprotein L and CMV UL130 originate from chemokinesDevelopment of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.Antibody inhibition of human cytomegalovirus spread in epithelial cell culturesImpact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cellsCytomegalovirus vaccines.Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.HCMV infection of human trophoblast progenitor cells of the placenta is neutralized by a human monoclonal antibody to glycoprotein B and not by antibodies to the pentamer complex.Human cytomegalovirus infection and atherothrombosis.Immune response to CMV in solid organ transplant recipients: current concepts and future directions.Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and ToledoGenetic Stability of Bacterial Artificial Chromosome-Derived Human Cytomegalovirus during Culture In Vitro.The proteome of human cytomegalovirus virions and dense bodies is conserved across different strains.Mutational mapping of pUL131A of human cytomegalovirus emphasizes its central role for endothelial cell tropism.Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.Identification of a Continuous Neutralizing Epitope within UL128 of Human Cytomegalovirus.Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
P2860
Q27000998-0E8E35B0-0FB6-4B48-9B63-E1E9082ADC57Q28550400-ADC55E4A-F95F-4F52-BB44-254D485E5CF0Q30514072-64E70FD4-68C5-4921-A2D0-B047E13A858CQ34902453-029AF4DB-C312-428A-9D94-FEF0B5759B75Q35076970-7E09B655-DDA5-4713-8502-7ADD9DA125EEQ35191120-E3E17592-C8F0-456B-8E28-E5EA8B9F95CEQ35609192-4261C457-DC8D-4FF3-B299-4931FD54C333Q35783065-76924FB3-CD55-488E-A6AB-EE17984F87DDQ35913890-BAA0E3E6-C13B-444F-B364-A90E799F919DQ36385141-21EA7C48-6F52-4C43-AB77-7B740BE082AAQ36559845-0CB3B53C-3A1F-461A-A386-9787F93CFA8CQ36687039-31587DC1-4EB3-4A84-822B-9E2954D8AF62Q36757818-6211C0AB-70E7-47BD-B3C6-FB5422390829Q37174327-0AB590D0-1524-4A9D-9D8C-157CAA5E5BD8Q37252891-80FAB371-CCE8-4C95-A292-25153D6171DEQ37332494-45528D64-9ECD-4C73-9689-EA9CD73D1E6DQ37350856-7C8B567F-CC5F-4EBB-B8A6-119398B7B710Q37563632-A1CEA2C2-9FD1-4DEB-8564-608462D96675Q37673149-D7B6FA05-76E9-4386-BBF7-B64581AD5FCEQ37967568-5B4526C9-6035-4902-A7D1-A76EB320D21DQ38011227-2B26C772-D353-435B-BE79-5D5558FB747CQ38708710-2A70AE71-94AA-4CA9-B489-2E23CF45F366Q38732965-8DCB8763-2F61-41EB-9EC8-2BB227B14AE5Q38796870-6AD7C4FC-9CD1-4545-B1D8-2307E813966DQ38904564-33C6DD8C-865E-42D7-96E0-F36528F0537FQ39451875-5E9A2414-BC0E-4344-B56D-CEAC0E2F759AQ40245011-4C24D575-8597-457F-A8F0-162B7858A19AQ40375876-B61A7F91-5F1B-40C8-B476-56DD8BBEFC24Q47605886-5654390B-1C7A-4A24-A18F-D9E4007A7C44Q57072187-181AC153-A1F2-46DD-9685-A90CDF7ADA72
P2860
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@ast
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@en
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@nl
type
label
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@ast
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@en
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@nl
prefLabel
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@ast
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@en
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@nl
P2093
P2860
P50
P1433
P1476
Peptides from cytomegalovirus ...... into mucosal epithelial cells
@en
P2093
Anne L Sauer
Brent J Ryckman
David C Johnson
Frances M Saccoccio
Michael A McVoy
Stuart P Adler
Xiaohong Cui
P2860
P304
P356
10.1016/J.VACCINE.2011.01.079
P407
P577
2011-02-22T00:00:00Z